blog

Minimizing Clinical Trial Disruption from COVID-19

By Elizabeth Gargill on Thu, Apr 2, 2020 | 2 min read

BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak. 

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer

 
Subscribe To Our Blog